Takanari Tatsumi

Nara-shi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Spatial proteomics deciphers the immune niche landscape of non-ampullary duodenal adenocarcinoma.

Spatial proteomics deciphers the immune niche landscape of non-ampullary duodenal adenocarcinoma.

Journal: British journal of cancer

Published: November 15, 2025

TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.

TONSL Promotes Hepatocellular Carcinoma Progression by Inhibiting Apoptosis Through Homologous Recombination Repair.

Journal: Cancer science

Published: November 11, 2025

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

NTAQ1 Promotes Hepatocellular Carcinoma Growth by Facilitating the Protein Degradation of the Tumor Suppressor PRDM2.

Journal: Cancer science

Published: October 26, 2025

Long-term complete response of early gastric cancer to nivolumab: report of a case with disease-free survival for six years.

Long-term complete response of early gastric cancer to nivolumab: report of a case with disease-free survival for six years.

Journal: Clinical journal of gastroenterology

Published: September 02, 2025

Elevated proportion of eosinophils predicts immune-related adverse events and improved survival in patients with gastric cancer treated with nivolumab.

Elevated proportion of eosinophils predicts immune-related adverse events and improved survival in patients with gastric cancer treated with nivolumab.

Journal: International journal of clinical oncology

Published: June 30, 2025

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

ZNF282 Promotes Colorectal Cancer Progression Possibly via E2F1 Activation.

Journal: Cancer science

Published: May 29, 2025

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: April 03, 2025

Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.

Polarity Gene PARD6B Promotes Tumor Growth of Colorectal Cancer via Increasing MYC Expression.

Journal: Cancer science

Published: January 05, 2025

Clinical and Biological Significance of Sodium Channel Modifier 1 as a Component of the Minor Spliceosome in Hepatocellular Carcinoma.

Clinical and Biological Significance of Sodium Channel Modifier 1 as a Component of the Minor Spliceosome in Hepatocellular Carcinoma.

Journal: Annals of surgical oncology

Published: January 03, 2025

SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.

SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.

Journal: International journal of oncology

Published: February 13, 2024

Association of perioperative oral swallowing function with post-esophagectomy outcomes and nutritional statuses in patients with esophageal cancer.

Association of perioperative oral swallowing function with post-esophagectomy outcomes and nutritional statuses in patients with esophageal cancer.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: December 27, 2023

The Prognostic Significance of Preoperative Anemia in Gastric Cancer Patients.

The Prognostic Significance of Preoperative Anemia in Gastric Cancer Patients.

Journal: In vivo (Athens, Greece)

Published: June 08, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026